Sands Capital Alternatives, LLC
ARLINGTON, VA · CIK 1846444 · 13F filing filed 2025-08-13
SEC-registered investment adviser since 2011 · limited liability company
- Assets managed$5.4bn
- Staff182 · 66 in investment roles
- Main clients (by assets)Private funds 97%, Pension plans 3%
- Private funds34 · $3.7bn gross assets
- Websitesandscapital.com
- Form ADV · 2026-07-28SEC adviser record
- Legal entitySANDS CAPITAL ALTERNATIVES, LLC (US)
- Kindhedge funds, private equity, venture, futures, wealth
- Others nearbyArlington, VA, London, San Francisco, CA, New York, NY, Charlottesville, VA, Singapore
- FamilySands Capital Alternatives, LLC · 2 related pages
As an employer
- Offices in3 countries
- Private fundsprivate equity 23, venture capital 11
Where they work
Offices
From Form ADV: the main office and the other offices where it does advisory work (at most the 25 largest), with the people doing investment work at each. “About” is worked out: the firm's investment staff less its other offices. Each city links to the other managers there.
| City | People |
|---|---|
| Arlington, VA (main office)United States | about 60 |
| Fitzrovia LondonUnited Kingdom | 2 |
| San Francisco, CAUnited States | 2 |
| New York City, NYUnited States | 1 |
| San Juan, PRUnited States | 1 |
| SingaporeSingapore |
Map: places from GeoNames (CC BY 4.0), outlines from Natural Earth.
Holdings, Q2 2025
The small lines show how much was held over the last 4 quarters (adjusted for stock splits).
| Security | Value | Change |
|---|---|---|
| KLAVIYO INC KVYO | $118.0m23.24% | Added +71.5k |
| NU HLDGS LTD NU | $98.4m19.39% | Added +11.1k |
| DOORDASH INC DASH | $94.0m18.50% | Added +498 |
| BETA BIONICS INC BBNX | $52.0m10.24% | Added +466.3k |
| COUPANG INC CPNG | $25.4m5.01% | Added +5.6k |
| INHIBIKASE THERAPEUTICS INC IKT | $21.4m4.20% | Unchanged |
| MONDAY COM LTD MNDY | $18.3m3.61% | Added +8.4k |
| SAMSARA INC IOT | $17.4m3.43% | Added +185.1k |
| DATADOG INC DDOG | $15.9m3.14% | Added +777 |
| CROWDSTRIKE HLDGS INC CRWD | $8.0m1.57% | Added +55 |
| TOAST INC TOST | $6.9m1.37% | Reduced -54.0k |
| TARSUS PHARMACEUTICALS INC TARS | $6.9m1.36% | Unchanged |
| SNOWFLAKE INC SNOW | $6.0m1.19% | Added +177 |
| 10X GENOMICS INC TXG | $5.6m1.10% | Unchanged |
| ACUMEN PHARMACEUTICALS INC ABOS | $4.0m0.78% | Unchanged |
| BIOAGE LABS INC BIOA | $3.2m0.64% | Unchanged |
| ACRIVON THERAPEUTICS INC ACRV | $2.5m0.50% | Unchanged |
| CANDEL THERAPEUTICS INC CADL | $2.1m0.40% | Unchanged |
| TAYSHA GENE THERAPIES INC TSHA | $1.7m0.33% | Unchanged |
Sold out since Q1 2025
| Security | Value then |
|---|---|
| UIPATH INC PATH | $4.1m395.9k shares |
Stakes above 5%
Companies where this manager has reported owning more than 5% of a class of shares, on Schedule 13D (may seek influence) or 13G (passive): its latest filing for each, from 19 Dec 2024 on.
| Company | Stake |
|---|---|
| ACUMEN PHARMACEUTICALS INC ABOS · 13G · filed 2025-08-13 | 5.6%≈ $9.1m |